Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS—a rosy future despite potential long-term safety concerns. Authorsʼ reply

Eamonn M.M. Quigley, Alex Stevenson, Ian Jeffery, Jacob Masters

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)347-348
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Issue number3
StatePublished - Feb 2023

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this